Spermatogenic Conversion

Series 2 is the sperm-producing pathway for clients seeking integrated phallic and scrotal anatomy while retaining the capacity to carry a pregnancy.

Sperm production
Core function
Established since 2037
Proven pathway
1 day procedure
Short-stay monitoring
4–5 weeks
Typical recovery

Clinical Overview

Loading model

A new reproductive role. Gestational continuity.

The spermatogenic-conversion pathway (Series 2) is designed around a new reproductive role. It introduces integrated phallic and scrotal anatomy, converts ovarian tissue into paired sperm-producing gonads, and preserves the uterus, vaginal anatomy, and capacity to carry a pregnancy.

The phallus is formed from a tissue-engineered graft grown from the client’s own cells, with its sensory foundation built around preserved clitoral tissue and neurovascular structures. The urethra is extended through the new anatomy, while the converted gonads are integrated within a newly formed scrotum with dedicated vascular, neural, and temperature-regulation support.

A specialized routing system directs most sperm-bearing fluid outward through the phallus while staging a smaller portion internally near the preserved uterus. This supports sperm-based conception with ovum-producing partners and allows the client to carry a pregnancy when a compatible ovum is provided.

Series 2 replaces ordinary ovarian ovum production, ovulation, and menstruation with a managed sperm-producing system. Pre-procedure egg retrieval and cryogenic storage are included to preserve future fertility options. For clients seeking complete phallic and scrotal anatomy, sperm-producing function, and retained gestational capability, Series 2 offers a distinct and complete NovaNex pathway.

Who Series 2 Is For

Designed for a new reproductive role

Series 2 may suit clients who want the added sexual, reproductive, and personal possibilities of transformation together with a sperm-producing reproductive role.

It is designed for clients drawn to integrated phallic and scrotal anatomy, a distinct reproductive profile, and the flexibility to contribute sperm while retaining the option to carry a pregnancy.

You want expanded possibilities

You are drawn to the added sexual, reproductive, and personal possibilities that come with integrated phallic and scrotal anatomy.

You prefer the Series 2 profile

You want phallic and scrotal anatomy together with a sperm-producing reproductive system as a complete, intentionally designed outcome.

You embrace sexual autonomy

You want a pathway that reflects your own sense of self, confidence, expression, and control over your body.

You want broader reproductive compatibility

You want reproductive compatibility with ovum-producing partners, including non-transformed women and Series 1 clients, while retaining your own gestational options.

What Changes, What Remains The Same

What Series 2 changes

Integrated phallic and scrotal anatomy

A fully sensate phallus with stable erectile function is paired with an external scrotum.

Extended urinary pathway

The urethra is routed through the phallus for natural urinary function.

Sperm-producing gonads

Ovarian tissue is converted into paired testes designed for stable sperm production.

Ejaculatory and internal sperm routing

Most sperm-bearing fluid is released through the phallus, while a smaller portion is staged internally.

Extended sensory and vascular pathways

Neural and vascular structures are integrated across the new phallic, scrotal, and gonadal anatomy.

What Series 2 preserves

Uterus

Gestational structure is retained and maintained in a ready-to-receive state.

Vaginal anatomy

Existing vaginal anatomy and receptive function are preserved.

Hormonal framework

A regulated hormonal framework continues without an ordinary ovulatory or menstrual cycle.

Capacity to carry a pregnancy

Clients retain the ability to conceive and gestate when a compatible ovum is provided.

Future fertility options

Egg retrieval and cryogenic storage are included before conversion to preserve future IVF choices.

Your Series 2 Care Pathway

1. Consultation

Your care pathway begins with a private consultation focused on your goals, medical history, anatomical preferences, and reproductive priorities. We'll explain how Series 2 changes gonadal function while preserving gestational capability, assess pathway suitability, and answer your questions before you decide how to proceed.

Timeframe
Day 1
Duration
About 1 hour
Outcome
Pathway recommendation

What to expect

  • Care coordinator assigned
  • Goals and anatomical preferences discussed
  • Medical and hormonal history reviewed
  • Pathway suitability evaluated
  • Fertility preservation options explained
  • Payment and access options reviewed

No commitment is required. You can review your pathway recommendation and fertility options before deciding whether to continue.

Consultation

Recovery and Clinical Confidence

Series 2 is designed for a short, closely monitored recovery despite its broader anatomical and gonadal scope. Clients remain under short-stay observation for 24–48 hours, usually return to many ordinary routines within days, and commonly receive progressive activity clearance around one month after treatment. Typical overall recovery spans 4–5 weeks. Temporary swelling, scrotal tenderness, sensitivity changes, urinary adjustment, and hormonal recalibration are expected parts of early adaptation.

24–48 hours

Short-stay monitoring

Within days

Return to ordinary routines

Around day 30

Typical activity clearance

Minimal visible scarring

Precision closure

What early recovery and adaptation can feel like

1.

Swelling and scrotal tenderness

Swelling, a sense of weight, and tenderness around the new scrotal anatomy are expected during the first days and usually improve steadily with support and rest.

2.

Sensitivity changes

Sensation may initially feel unusually strong, muted, or inconsistent as the extended neural pathways and gonadal tissues settle.

3.

Urinary adjustment

Urination may feel unfamiliar while adapting to the extended urinary pathway, but early changes are usually mild and short-term.

4.

Spontaneous erections

Unexpected erections can occur during neural recovery. Your care plan explains positioning, support, and when to contact the team if discomfort persists.

5.

Sitting, movement, and support

Sitting, walking, and changing position can feel different at first. Supportive underwear and softer seating help protect the scrotal area while swelling settles.

6.

Hormonal and fertility stabilization

Energy, temperature awareness, and reproductive timing may feel temporarily different while the converted gonads and regulated hormonal framework stabilize.

If anything feels concerning or outside expectations, your NovaNex care team is available around the clock during early recovery.

Clinical confidence and follow-up

Series 2 combines predictive screening, personalized biological mapping, robotic neurovascular alignment, gonadal tissue-viability monitoring, and structured endocrine follow-up to support dependable integration across the complete pathway.

Temporary concerns such as prolonged localized swelling, sensitivity variation, urinary recalibration, or slower hormonal stabilization are usually managed through guidance, short-term medication, supportive care, or outpatient review.

Clinically significant integration, urinary, endocrine, or fertility concerns are uncommon. Scheduled follow-up helps identify changes early and coordinate targeted treatment or refinement when additional support is needed.

Typical follow-up includes

  • short-stay tissue and circulation monitoring before discharge
  • gonadal integration and endocrine review during the first two weeks
  • urinary, erectile, and scrotal comfort assessment
  • sperm-production and fertility testing after stabilization

Most

recover without
clinical adjustment

Uncommon

moderate complications

Rare

serious adverse outcomes

Real Stories, Real Confidence

Sofia, 27

Series 2

"Series 2 felt like a big decision, but not a reckless one. The medical team made the science feel understandable and the choice feel fully mine."

Jun, 19

Series 2

"I was nervous before my first consultation, but nobody rushed me. They answered the awkward questions with the same care as the easy ones."

Priya, 38

Series 2

"For us, Series 2 was about partnership. I wanted to take on a different role in creating our family, and NovaNex helped make that possible."

Pricing & Financing

Choose your payment plan

Age at the time of your procedure
How would you like to pay?
Choose a payment term

Choose a down payment

$380
0%50%

Payment summary

Series 2 program fee$9,500.00
Under-27 access credit-$1,900.00
Down payment$380.00
Amount financed$7,220.00
Fixed financing charge$0.00
Setup fee$295.00
Everwell Medical Finance

$675.00 due initially, then

$200.56/month

$7,895.00 total payable

Book an appointment

Financing provided by Everwell Medical Finance. Eligibility is confirmed before scheduling.

Common Questions

Series 2 is NovaNex's sperm-producing transformation pathway. It adds integrated phallic and scrotal anatomy, converts ovarian tissue into paired sperm-producing gonads, and preserves the uterus and capacity to carry a pregnancy.